Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #244929 on Innovation Pharmaceuticals Inc (IPIX)
MinnieM
10/15/18 4:22 PM
#244935 RE: MXAMDUD #244929
The Company signed a non-binding term sheet in August 2018 with a global pharmaceutical company for the licensing/rights to Brilacidin for treating oral mucositis and inflammatory bowel diseases. Initial payments, milestone payments and royalties are being negotiated in accordance with the non-binding term sheet. The pharmaceutical company is now engaged in further due diligence. Management can offer no assurances that the parties will enter into a binding definitive agreement.